Endothelial injury in the initiation and progression of vascular disorders (Q36705621)

15 August 2017

1 reference

title

Endothelial injury in the initiation and progression of vascular disorders (English)

1 reference

15 August 2017

0 references

Belay Tesfamariam

1

1 reference

15 August 2017

Albert F DeFelice

series ordinal

2

1 reference

15 August 2017

publication date

6 December 2006

1 reference

15 August 2017

published in

Vascular Pharmacology

1 reference

15 August 2017

volume

46

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

229-237

1 reference

Arteriopathy induced by an adenosine agonist-antihypertensive in monkeys

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Studies on coronary arteriopathy in dogs following administration of CI-1020, an endothelin A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. The Shwartzman reaction revisited

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Biomarkers of drug-induced vascular injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Differentiating spontaneous from drug-induced vascular injury in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Dynamic pattern of endothelial cell adhesion molecule expression in muscle and perineural vessels from patients with classic polyarteritis nodosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Circulating markers of endothelial function in cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Cardiotoxicity of vasodilators and positive inotropic/vasodilating drugs in dogs: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Detection of antiendothelial cell antibodies by an enzyme-linked immunosorbent assay using antigens from cell lysate: minimal interference with antinuclear antibodies and rheumatoid factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Acute drug-induced vascular injury in beagle dogs: pathology and correlating genomic expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Arterial lesions induced by phosphodiesterase III (PDE III) inhibitors and DA(1) agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Drug-induced vascular injury--a quest for biomarkers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Functional properties of antiendothelial cell antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener's granulomatosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Pathology and pathophysiology of drug-induced arterial injury in laboratory animals and its implications on the evaluation of novel chemical entities for human clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Biomarkers and mechanisms of drug-induced vascular injury in non-rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Multiple functions of caveolin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Oxidant stress and endothelial cell dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Involvement of Tumor Necrosis Factor-α in the Development of T Cell–Dependent Aortitis in Interleukin-1 Receptor Antagonist–Deficient Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Relationship between serum concentrations, hemodynamic effects, and cardiovascular lesions in dogs treated with minoxidil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

7 January 2021

Drug-induced vasculitis

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Fluid shear stress and the vascular endothelium: for better and for worse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Free radicals in diabetic endothelial cell dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Differential expression and regulation of murine CD40 in regional vascular beds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Conversion of xanthine dehydrogenase to xanthine oxidase in bovine carotid artery endothelial cells induced by activated neutrophils: involvement of adhesion molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Expression of CD40 ligand on CD4 T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Pathogenic mechanisms in giant cell arteritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

The clinical implications of endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

SK&F 95654-induced acute cardiovascular toxicity in Sprague-Dawley rats--histopathologic, electron microscopic, and immunohistochemical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2006.11.005

10.1016/J.VPH.2006.11.005

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference